Article | June 23, 2022

Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials

Source: Kayentis
GettyImages-1315159023 oncology ps

Many of the challenges of clinical trials are well known, but oncology trials differ from other therapeutic areas: not only are the protocols usually more complex, but they also often last longer than other therapeutic area studies. This brings specific challenges that lead to oncology clinical trials having one of the lowest success rate.

The addition of technical components can help mitigate these challenges, by bringing simplicity, offering flexibility, and smoothing the flow of oncology clinical trials processes. But how can the technical components be well selected and smoothly implemented so that they support the success of eCOA trials? This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader